nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—Nucleoside Analog—Azathioprine—systemic scleroderma	0.661	1	CiPCiCtD
Valaciclovir—SLC15A1—Lisinopril—systemic scleroderma	0.095	0.404	CbGbCtD
Valaciclovir—SLC15A1—Captopril—systemic scleroderma	0.0711	0.302	CbGbCtD
Valaciclovir—SLC22A6—Captopril—systemic scleroderma	0.0392	0.166	CbGbCtD
Valaciclovir—SLC22A8—Methotrexate—systemic scleroderma	0.0178	0.0755	CbGbCtD
Valaciclovir—SLC22A6—Methotrexate—systemic scleroderma	0.0124	0.0526	CbGbCtD
Valaciclovir—Asthenia—Captopril—systemic scleroderma	0.000102	0.000994	CcSEcCtD
Valaciclovir—Dermatitis—Mometasone—systemic scleroderma	0.000102	0.000993	CcSEcCtD
Valaciclovir—Decreased appetite—Leflunomide—systemic scleroderma	0.000102	0.000992	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000102	0.000992	CcSEcCtD
Valaciclovir—Osteoarthritis—Methotrexate—systemic scleroderma	0.000102	0.00099	CcSEcCtD
Valaciclovir—Confusional state—Lisinopril—systemic scleroderma	0.000102	0.000989	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000102	0.000988	CcSEcCtD
Valaciclovir—Headache—Mometasone—systemic scleroderma	0.000102	0.000988	CcSEcCtD
Valaciclovir—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000986	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000101	0.000985	CcSEcCtD
Valaciclovir—Insomnia—Mycophenolic acid—systemic scleroderma	0.000101	0.000985	CcSEcCtD
Valaciclovir—Fatigue—Leflunomide—systemic scleroderma	0.000101	0.000984	CcSEcCtD
Valaciclovir—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000101	0.000981	CcSEcCtD
Valaciclovir—Oedema—Lisinopril—systemic scleroderma	0.000101	0.000981	CcSEcCtD
Valaciclovir—Pruritus—Captopril—systemic scleroderma	0.000101	0.00098	CcSEcCtD
Valaciclovir—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000101	0.000978	CcSEcCtD
Valaciclovir—Constipation—Leflunomide—systemic scleroderma	0.000101	0.000976	CcSEcCtD
Valaciclovir—Pain—Leflunomide—systemic scleroderma	0.000101	0.000976	CcSEcCtD
Valaciclovir—Infection—Lisinopril—systemic scleroderma	0.0001	0.000974	CcSEcCtD
Valaciclovir—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.0001	0.000973	CcSEcCtD
Valaciclovir—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.0001	0.000971	CcSEcCtD
Valaciclovir—Somnolence—Mycophenolic acid—systemic scleroderma	9.97e-05	0.000968	CcSEcCtD
Valaciclovir—Agitation—Mycophenolate mofetil—systemic scleroderma	9.96e-05	0.000967	CcSEcCtD
Valaciclovir—Angioedema—Mycophenolate mofetil—systemic scleroderma	9.91e-05	0.000962	CcSEcCtD
Valaciclovir—Thrombocytopenia—Lisinopril—systemic scleroderma	9.89e-05	0.00096	CcSEcCtD
Valaciclovir—Dyspepsia—Mycophenolic acid—systemic scleroderma	9.87e-05	0.000958	CcSEcCtD
Valaciclovir—Tachycardia—Lisinopril—systemic scleroderma	9.86e-05	0.000957	CcSEcCtD
Valaciclovir—Abdominal pain—Azathioprine—systemic scleroderma	9.84e-05	0.000955	CcSEcCtD
Valaciclovir—Body temperature increased—Azathioprine—systemic scleroderma	9.84e-05	0.000955	CcSEcCtD
Valaciclovir—Skin disorder—Lisinopril—systemic scleroderma	9.81e-05	0.000953	CcSEcCtD
Valaciclovir—Diarrhoea—Captopril—systemic scleroderma	9.76e-05	0.000947	CcSEcCtD
Valaciclovir—Decreased appetite—Mycophenolic acid—systemic scleroderma	9.75e-05	0.000946	CcSEcCtD
Valaciclovir—Leukopenia—Mycophenolate mofetil—systemic scleroderma	9.71e-05	0.000942	CcSEcCtD
Valaciclovir—Feeling abnormal—Leflunomide—systemic scleroderma	9.69e-05	0.00094	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	9.68e-05	0.00094	CcSEcCtD
Valaciclovir—Fatigue—Mycophenolic acid—systemic scleroderma	9.67e-05	0.000939	CcSEcCtD
Valaciclovir—Nausea—Mometasone—systemic scleroderma	9.64e-05	0.000936	CcSEcCtD
Valaciclovir—Anorexia—Lisinopril—systemic scleroderma	9.63e-05	0.000935	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Leflunomide—systemic scleroderma	9.61e-05	0.000933	CcSEcCtD
Valaciclovir—Ataxia—Methotrexate—systemic scleroderma	9.59e-05	0.000931	CcSEcCtD
Valaciclovir—Pain—Mycophenolic acid—systemic scleroderma	9.59e-05	0.000931	CcSEcCtD
Valaciclovir—Constipation—Mycophenolic acid—systemic scleroderma	9.59e-05	0.000931	CcSEcCtD
Valaciclovir—Cough—Mycophenolate mofetil—systemic scleroderma	9.46e-05	0.000919	CcSEcCtD
Valaciclovir—Dizziness—Captopril—systemic scleroderma	9.43e-05	0.000916	CcSEcCtD
Valaciclovir—Liver function test abnormal—Methotrexate—systemic scleroderma	9.42e-05	0.000914	CcSEcCtD
Valaciclovir—Convulsion—Mycophenolate mofetil—systemic scleroderma	9.39e-05	0.000912	CcSEcCtD
Valaciclovir—Depression—Prednisone—systemic scleroderma	9.38e-05	0.000911	CcSEcCtD
Valaciclovir—Hypertension—Mycophenolate mofetil—systemic scleroderma	9.36e-05	0.000909	CcSEcCtD
Valaciclovir—Urticaria—Leflunomide—systemic scleroderma	9.34e-05	0.000907	CcSEcCtD
Valaciclovir—Abdominal pain—Leflunomide—systemic scleroderma	9.29e-05	0.000902	CcSEcCtD
Valaciclovir—Body temperature increased—Leflunomide—systemic scleroderma	9.29e-05	0.000902	CcSEcCtD
Valaciclovir—Feeling abnormal—Mycophenolic acid—systemic scleroderma	9.24e-05	0.000897	CcSEcCtD
Valaciclovir—Chest pain—Mycophenolate mofetil—systemic scleroderma	9.23e-05	0.000896	CcSEcCtD
Valaciclovir—Myalgia—Mycophenolate mofetil—systemic scleroderma	9.23e-05	0.000896	CcSEcCtD
Valaciclovir—Arthralgia—Mycophenolate mofetil—systemic scleroderma	9.23e-05	0.000896	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	9.2e-05	0.000893	CcSEcCtD
Valaciclovir—Hypersensitivity—Azathioprine—systemic scleroderma	9.17e-05	0.00089	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	9.17e-05	0.00089	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	9.17e-05	0.00089	CcSEcCtD
Valaciclovir—Insomnia—Lisinopril—systemic scleroderma	9.13e-05	0.000887	CcSEcCtD
Valaciclovir—Paraesthesia—Lisinopril—systemic scleroderma	9.07e-05	0.000881	CcSEcCtD
Valaciclovir—Vomiting—Captopril—systemic scleroderma	9.07e-05	0.00088	CcSEcCtD
Valaciclovir—Dry mouth—Mycophenolate mofetil—systemic scleroderma	9.03e-05	0.000877	CcSEcCtD
Valaciclovir—Dyspnoea—Lisinopril—systemic scleroderma	9e-05	0.000874	CcSEcCtD
Valaciclovir—Rash—Captopril—systemic scleroderma	8.99e-05	0.000873	CcSEcCtD
Valaciclovir—Dermatitis—Captopril—systemic scleroderma	8.98e-05	0.000872	CcSEcCtD
Valaciclovir—Somnolence—Lisinopril—systemic scleroderma	8.98e-05	0.000872	CcSEcCtD
Valaciclovir—Headache—Captopril—systemic scleroderma	8.93e-05	0.000867	CcSEcCtD
Valaciclovir—Confusional state—Mycophenolate mofetil—systemic scleroderma	8.92e-05	0.000866	CcSEcCtD
Valaciclovir—Dyspepsia—Lisinopril—systemic scleroderma	8.89e-05	0.000863	CcSEcCtD
Valaciclovir—Body temperature increased—Mycophenolic acid—systemic scleroderma	8.86e-05	0.000861	CcSEcCtD
Valaciclovir—Abdominal pain—Mycophenolic acid—systemic scleroderma	8.86e-05	0.000861	CcSEcCtD
Valaciclovir—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	8.85e-05	0.000859	CcSEcCtD
Valaciclovir—Oedema—Mycophenolate mofetil—systemic scleroderma	8.85e-05	0.000859	CcSEcCtD
Valaciclovir—Infection—Mycophenolate mofetil—systemic scleroderma	8.79e-05	0.000854	CcSEcCtD
Valaciclovir—Decreased appetite—Lisinopril—systemic scleroderma	8.78e-05	0.000852	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Lisinopril—systemic scleroderma	8.72e-05	0.000847	CcSEcCtD
Valaciclovir—Fatigue—Lisinopril—systemic scleroderma	8.71e-05	0.000845	CcSEcCtD
Valaciclovir—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	8.68e-05	0.000843	CcSEcCtD
Valaciclovir—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	8.66e-05	0.000841	CcSEcCtD
Valaciclovir—Hypersensitivity—Leflunomide—systemic scleroderma	8.66e-05	0.000841	CcSEcCtD
Valaciclovir—Pain—Lisinopril—systemic scleroderma	8.64e-05	0.000839	CcSEcCtD
Valaciclovir—Constipation—Lisinopril—systemic scleroderma	8.64e-05	0.000839	CcSEcCtD
Valaciclovir—Tachycardia—Mycophenolate mofetil—systemic scleroderma	8.64e-05	0.000839	CcSEcCtD
Valaciclovir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	8.59e-05	0.000835	CcSEcCtD
Valaciclovir—Diarrhoea—Azathioprine—systemic scleroderma	8.52e-05	0.000827	CcSEcCtD
Valaciclovir—Nausea—Captopril—systemic scleroderma	8.47e-05	0.000823	CcSEcCtD
Valaciclovir—Abdominal discomfort—Methotrexate—systemic scleroderma	8.45e-05	0.000821	CcSEcCtD
Valaciclovir—Anorexia—Mycophenolate mofetil—systemic scleroderma	8.43e-05	0.000819	CcSEcCtD
Valaciclovir—Asthenia—Leflunomide—systemic scleroderma	8.43e-05	0.000819	CcSEcCtD
Valaciclovir—Hallucination—Prednisone—systemic scleroderma	8.4e-05	0.000816	CcSEcCtD
Valaciclovir—Feeling abnormal—Lisinopril—systemic scleroderma	8.32e-05	0.000808	CcSEcCtD
Valaciclovir—Pruritus—Leflunomide—systemic scleroderma	8.32e-05	0.000807	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Lisinopril—systemic scleroderma	8.26e-05	0.000802	CcSEcCtD
Valaciclovir—Dizziness—Azathioprine—systemic scleroderma	8.23e-05	0.000799	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Methotrexate—systemic scleroderma	8.19e-05	0.000796	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	8.06e-05	0.000783	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Methotrexate—systemic scleroderma	8.05e-05	0.000781	CcSEcCtD
Valaciclovir—Asthenia—Mycophenolic acid—systemic scleroderma	8.04e-05	0.000781	CcSEcCtD
Valaciclovir—Diarrhoea—Leflunomide—systemic scleroderma	8.04e-05	0.000781	CcSEcCtD
Valaciclovir—Urticaria—Lisinopril—systemic scleroderma	8.02e-05	0.000779	CcSEcCtD
Valaciclovir—Insomnia—Mycophenolate mofetil—systemic scleroderma	8e-05	0.000777	CcSEcCtD
Valaciclovir—Body temperature increased—Lisinopril—systemic scleroderma	7.98e-05	0.000775	CcSEcCtD
Valaciclovir—Abdominal pain—Lisinopril—systemic scleroderma	7.98e-05	0.000775	CcSEcCtD
Valaciclovir—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	7.95e-05	0.000772	CcSEcCtD
Valaciclovir—Pruritus—Mycophenolic acid—systemic scleroderma	7.93e-05	0.00077	CcSEcCtD
Valaciclovir—Vomiting—Azathioprine—systemic scleroderma	7.91e-05	0.000768	CcSEcCtD
Valaciclovir—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	7.89e-05	0.000766	CcSEcCtD
Valaciclovir—Somnolence—Mycophenolate mofetil—systemic scleroderma	7.87e-05	0.000764	CcSEcCtD
Valaciclovir—Rash—Azathioprine—systemic scleroderma	7.85e-05	0.000762	CcSEcCtD
Valaciclovir—Dermatitis—Azathioprine—systemic scleroderma	7.84e-05	0.000761	CcSEcCtD
Valaciclovir—Depression—Methotrexate—systemic scleroderma	7.84e-05	0.000761	CcSEcCtD
Valaciclovir—Headache—Azathioprine—systemic scleroderma	7.8e-05	0.000757	CcSEcCtD
Valaciclovir—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	7.79e-05	0.000756	CcSEcCtD
Valaciclovir—Dizziness—Leflunomide—systemic scleroderma	7.77e-05	0.000755	CcSEcCtD
Valaciclovir—Renal failure—Methotrexate—systemic scleroderma	7.73e-05	0.00075	CcSEcCtD
Valaciclovir—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	7.69e-05	0.000747	CcSEcCtD
Valaciclovir—Diarrhoea—Mycophenolic acid—systemic scleroderma	7.67e-05	0.000745	CcSEcCtD
Valaciclovir—Stomatitis—Methotrexate—systemic scleroderma	7.66e-05	0.000744	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	7.64e-05	0.000742	CcSEcCtD
Valaciclovir—Immune system disorder—Prednisone—systemic scleroderma	7.63e-05	0.00074	CcSEcCtD
Valaciclovir—Pain—Mycophenolate mofetil—systemic scleroderma	7.57e-05	0.000735	CcSEcCtD
Valaciclovir—Constipation—Mycophenolate mofetil—systemic scleroderma	7.57e-05	0.000735	CcSEcCtD
Valaciclovir—Haematuria—Methotrexate—systemic scleroderma	7.49e-05	0.000728	CcSEcCtD
Valaciclovir—Vomiting—Leflunomide—systemic scleroderma	7.47e-05	0.000726	CcSEcCtD
Valaciclovir—Alopecia—Prednisone—systemic scleroderma	7.46e-05	0.000724	CcSEcCtD
Valaciclovir—Hypersensitivity—Lisinopril—systemic scleroderma	7.44e-05	0.000722	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Methotrexate—systemic scleroderma	7.43e-05	0.000722	CcSEcCtD
Valaciclovir—Dizziness—Mycophenolic acid—systemic scleroderma	7.41e-05	0.00072	CcSEcCtD
Valaciclovir—Rash—Leflunomide—systemic scleroderma	7.41e-05	0.00072	CcSEcCtD
Valaciclovir—Dermatitis—Leflunomide—systemic scleroderma	7.4e-05	0.000719	CcSEcCtD
Valaciclovir—Nausea—Azathioprine—systemic scleroderma	7.39e-05	0.000718	CcSEcCtD
Valaciclovir—Headache—Leflunomide—systemic scleroderma	7.36e-05	0.000715	CcSEcCtD
Valaciclovir—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	7.29e-05	0.000708	CcSEcCtD
Valaciclovir—Asthenia—Lisinopril—systemic scleroderma	7.25e-05	0.000704	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	7.24e-05	0.000703	CcSEcCtD
Valaciclovir—Pruritus—Lisinopril—systemic scleroderma	7.15e-05	0.000694	CcSEcCtD
Valaciclovir—Vomiting—Mycophenolic acid—systemic scleroderma	7.13e-05	0.000692	CcSEcCtD
Valaciclovir—Rash—Mycophenolic acid—systemic scleroderma	7.07e-05	0.000686	CcSEcCtD
Valaciclovir—Dermatitis—Mycophenolic acid—systemic scleroderma	7.06e-05	0.000686	CcSEcCtD
Valaciclovir—Hepatitis—Methotrexate—systemic scleroderma	7.06e-05	0.000685	CcSEcCtD
Valaciclovir—Urticaria—Mycophenolate mofetil—systemic scleroderma	7.03e-05	0.000683	CcSEcCtD
Valaciclovir—Headache—Mycophenolic acid—systemic scleroderma	7.02e-05	0.000682	CcSEcCtD
Valaciclovir—Pharyngitis—Methotrexate—systemic scleroderma	7e-05	0.00068	CcSEcCtD
Valaciclovir—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	7e-05	0.000679	CcSEcCtD
Valaciclovir—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	7e-05	0.000679	CcSEcCtD
Valaciclovir—Nausea—Leflunomide—systemic scleroderma	6.98e-05	0.000678	CcSEcCtD
Valaciclovir—Urinary tract disorder—Methotrexate—systemic scleroderma	6.97e-05	0.000677	CcSEcCtD
Valaciclovir—Urethral disorder—Methotrexate—systemic scleroderma	6.92e-05	0.000672	CcSEcCtD
Valaciclovir—Diarrhoea—Lisinopril—systemic scleroderma	6.91e-05	0.000671	CcSEcCtD
Valaciclovir—Anaemia—Prednisone—systemic scleroderma	6.79e-05	0.00066	CcSEcCtD
Valaciclovir—Agitation—Prednisone—systemic scleroderma	6.75e-05	0.000656	CcSEcCtD
Valaciclovir—Angioedema—Prednisone—systemic scleroderma	6.72e-05	0.000652	CcSEcCtD
Valaciclovir—Dizziness—Lisinopril—systemic scleroderma	6.68e-05	0.000648	CcSEcCtD
Valaciclovir—Erythema multiforme—Methotrexate—systemic scleroderma	6.67e-05	0.000648	CcSEcCtD
Valaciclovir—Nausea—Mycophenolic acid—systemic scleroderma	6.66e-05	0.000647	CcSEcCtD
Valaciclovir—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	6.52e-05	0.000633	CcSEcCtD
Valaciclovir—Vomiting—Lisinopril—systemic scleroderma	6.42e-05	0.000624	CcSEcCtD
Valaciclovir—Immune system disorder—Methotrexate—systemic scleroderma	6.37e-05	0.000619	CcSEcCtD
Valaciclovir—Rash—Lisinopril—systemic scleroderma	6.37e-05	0.000618	CcSEcCtD
Valaciclovir—Convulsion—Prednisone—systemic scleroderma	6.37e-05	0.000618	CcSEcCtD
Valaciclovir—Dermatitis—Lisinopril—systemic scleroderma	6.36e-05	0.000618	CcSEcCtD
Valaciclovir—Mediastinal disorder—Methotrexate—systemic scleroderma	6.36e-05	0.000617	CcSEcCtD
Valaciclovir—Asthenia—Mycophenolate mofetil—systemic scleroderma	6.35e-05	0.000616	CcSEcCtD
Valaciclovir—Hypertension—Prednisone—systemic scleroderma	6.35e-05	0.000616	CcSEcCtD
Valaciclovir—Chills—Methotrexate—systemic scleroderma	6.33e-05	0.000615	CcSEcCtD
Valaciclovir—Headache—Lisinopril—systemic scleroderma	6.33e-05	0.000614	CcSEcCtD
Valaciclovir—Pruritus—Mycophenolate mofetil—systemic scleroderma	6.26e-05	0.000608	CcSEcCtD
Valaciclovir—Arthralgia—Prednisone—systemic scleroderma	6.26e-05	0.000608	CcSEcCtD
Valaciclovir—Myalgia—Prednisone—systemic scleroderma	6.26e-05	0.000608	CcSEcCtD
Valaciclovir—Alopecia—Methotrexate—systemic scleroderma	6.23e-05	0.000605	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	6.21e-05	0.000603	CcSEcCtD
Valaciclovir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	6.05e-05	0.000588	CcSEcCtD
Valaciclovir—Nausea—Lisinopril—systemic scleroderma	6e-05	0.000582	CcSEcCtD
Valaciclovir—Anaphylactic shock—Prednisone—systemic scleroderma	6e-05	0.000582	CcSEcCtD
Valaciclovir—Oedema—Prednisone—systemic scleroderma	6e-05	0.000582	CcSEcCtD
Valaciclovir—Infection—Prednisone—systemic scleroderma	5.96e-05	0.000579	CcSEcCtD
Valaciclovir—Back pain—Methotrexate—systemic scleroderma	5.94e-05	0.000577	CcSEcCtD
Valaciclovir—Nervous system disorder—Prednisone—systemic scleroderma	5.88e-05	0.000571	CcSEcCtD
Valaciclovir—Tachycardia—Prednisone—systemic scleroderma	5.85e-05	0.000568	CcSEcCtD
Valaciclovir—Dizziness—Mycophenolate mofetil—systemic scleroderma	5.85e-05	0.000568	CcSEcCtD
Valaciclovir—Skin disorder—Prednisone—systemic scleroderma	5.83e-05	0.000566	CcSEcCtD
Valaciclovir—Anorexia—Prednisone—systemic scleroderma	5.72e-05	0.000555	CcSEcCtD
Valaciclovir—Anaemia—Methotrexate—systemic scleroderma	5.68e-05	0.000551	CcSEcCtD
Valaciclovir—Vomiting—Mycophenolate mofetil—systemic scleroderma	5.63e-05	0.000546	CcSEcCtD
Valaciclovir—Rash—Mycophenolate mofetil—systemic scleroderma	5.58e-05	0.000542	CcSEcCtD
Valaciclovir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	5.57e-05	0.000541	CcSEcCtD
Valaciclovir—Headache—Mycophenolate mofetil—systemic scleroderma	5.54e-05	0.000538	CcSEcCtD
Valaciclovir—Leukopenia—Methotrexate—systemic scleroderma	5.5e-05	0.000534	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Prednisone—systemic scleroderma	5.46e-05	0.000531	CcSEcCtD
Valaciclovir—Insomnia—Prednisone—systemic scleroderma	5.43e-05	0.000527	CcSEcCtD
Valaciclovir—Paraesthesia—Prednisone—systemic scleroderma	5.39e-05	0.000523	CcSEcCtD
Valaciclovir—Cough—Methotrexate—systemic scleroderma	5.36e-05	0.00052	CcSEcCtD
Valaciclovir—Convulsion—Methotrexate—systemic scleroderma	5.32e-05	0.000517	CcSEcCtD
Valaciclovir—Dyspepsia—Prednisone—systemic scleroderma	5.28e-05	0.000513	CcSEcCtD
Valaciclovir—Nausea—Mycophenolate mofetil—systemic scleroderma	5.26e-05	0.00051	CcSEcCtD
Valaciclovir—Arthralgia—Methotrexate—systemic scleroderma	5.23e-05	0.000508	CcSEcCtD
Valaciclovir—Chest pain—Methotrexate—systemic scleroderma	5.23e-05	0.000508	CcSEcCtD
Valaciclovir—Myalgia—Methotrexate—systemic scleroderma	5.23e-05	0.000508	CcSEcCtD
Valaciclovir—Decreased appetite—Prednisone—systemic scleroderma	5.21e-05	0.000506	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	5.19e-05	0.000504	CcSEcCtD
Valaciclovir—Fatigue—Prednisone—systemic scleroderma	5.17e-05	0.000502	CcSEcCtD
Valaciclovir—Constipation—Prednisone—systemic scleroderma	5.13e-05	0.000498	CcSEcCtD
Valaciclovir—Confusional state—Methotrexate—systemic scleroderma	5.05e-05	0.000491	CcSEcCtD
Valaciclovir—Anaphylactic shock—Methotrexate—systemic scleroderma	5.01e-05	0.000487	CcSEcCtD
Valaciclovir—Infection—Methotrexate—systemic scleroderma	4.98e-05	0.000484	CcSEcCtD
Valaciclovir—Feeling abnormal—Prednisone—systemic scleroderma	4.94e-05	0.00048	CcSEcCtD
Valaciclovir—Nervous system disorder—Methotrexate—systemic scleroderma	4.92e-05	0.000477	CcSEcCtD
Valaciclovir—Thrombocytopenia—Methotrexate—systemic scleroderma	4.91e-05	0.000477	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Prednisone—systemic scleroderma	4.9e-05	0.000476	CcSEcCtD
Valaciclovir—Skin disorder—Methotrexate—systemic scleroderma	4.87e-05	0.000473	CcSEcCtD
Valaciclovir—Anorexia—Methotrexate—systemic scleroderma	4.78e-05	0.000464	CcSEcCtD
Valaciclovir—Urticaria—Prednisone—systemic scleroderma	4.76e-05	0.000463	CcSEcCtD
Valaciclovir—Body temperature increased—Prednisone—systemic scleroderma	4.74e-05	0.00046	CcSEcCtD
Valaciclovir—Abdominal pain—Prednisone—systemic scleroderma	4.74e-05	0.00046	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	4.57e-05	0.000443	CcSEcCtD
Valaciclovir—Insomnia—Methotrexate—systemic scleroderma	4.53e-05	0.00044	CcSEcCtD
Valaciclovir—Paraesthesia—Methotrexate—systemic scleroderma	4.5e-05	0.000437	CcSEcCtD
Valaciclovir—Dyspnoea—Methotrexate—systemic scleroderma	4.47e-05	0.000434	CcSEcCtD
Valaciclovir—Somnolence—Methotrexate—systemic scleroderma	4.46e-05	0.000433	CcSEcCtD
Valaciclovir—Hypersensitivity—Prednisone—systemic scleroderma	4.42e-05	0.000429	CcSEcCtD
Valaciclovir—Dyspepsia—Methotrexate—systemic scleroderma	4.41e-05	0.000428	CcSEcCtD
Valaciclovir—Decreased appetite—Methotrexate—systemic scleroderma	4.36e-05	0.000423	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Methotrexate—systemic scleroderma	4.33e-05	0.00042	CcSEcCtD
Valaciclovir—Fatigue—Methotrexate—systemic scleroderma	4.32e-05	0.00042	CcSEcCtD
Valaciclovir—Asthenia—Prednisone—systemic scleroderma	4.3e-05	0.000418	CcSEcCtD
Valaciclovir—Pain—Methotrexate—systemic scleroderma	4.29e-05	0.000416	CcSEcCtD
Valaciclovir—Pruritus—Prednisone—systemic scleroderma	4.24e-05	0.000412	CcSEcCtD
Valaciclovir—Feeling abnormal—Methotrexate—systemic scleroderma	4.13e-05	0.000401	CcSEcCtD
Valaciclovir—Diarrhoea—Prednisone—systemic scleroderma	4.1e-05	0.000398	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Methotrexate—systemic scleroderma	4.1e-05	0.000398	CcSEcCtD
Valaciclovir—Urticaria—Methotrexate—systemic scleroderma	3.98e-05	0.000387	CcSEcCtD
Valaciclovir—Dizziness—Prednisone—systemic scleroderma	3.97e-05	0.000385	CcSEcCtD
Valaciclovir—Body temperature increased—Methotrexate—systemic scleroderma	3.96e-05	0.000385	CcSEcCtD
Valaciclovir—Abdominal pain—Methotrexate—systemic scleroderma	3.96e-05	0.000385	CcSEcCtD
Valaciclovir—Vomiting—Prednisone—systemic scleroderma	3.81e-05	0.00037	CcSEcCtD
Valaciclovir—Rash—Prednisone—systemic scleroderma	3.78e-05	0.000367	CcSEcCtD
Valaciclovir—Dermatitis—Prednisone—systemic scleroderma	3.78e-05	0.000367	CcSEcCtD
Valaciclovir—Headache—Prednisone—systemic scleroderma	3.76e-05	0.000365	CcSEcCtD
Valaciclovir—Hypersensitivity—Methotrexate—systemic scleroderma	3.69e-05	0.000359	CcSEcCtD
Valaciclovir—Asthenia—Methotrexate—systemic scleroderma	3.6e-05	0.000349	CcSEcCtD
Valaciclovir—Nausea—Prednisone—systemic scleroderma	3.56e-05	0.000346	CcSEcCtD
Valaciclovir—Pruritus—Methotrexate—systemic scleroderma	3.55e-05	0.000344	CcSEcCtD
Valaciclovir—Diarrhoea—Methotrexate—systemic scleroderma	3.43e-05	0.000333	CcSEcCtD
Valaciclovir—Dizziness—Methotrexate—systemic scleroderma	3.31e-05	0.000322	CcSEcCtD
Valaciclovir—Vomiting—Methotrexate—systemic scleroderma	3.19e-05	0.000309	CcSEcCtD
Valaciclovir—Rash—Methotrexate—systemic scleroderma	3.16e-05	0.000307	CcSEcCtD
Valaciclovir—Dermatitis—Methotrexate—systemic scleroderma	3.16e-05	0.000307	CcSEcCtD
Valaciclovir—Headache—Methotrexate—systemic scleroderma	3.14e-05	0.000305	CcSEcCtD
Valaciclovir—Nausea—Methotrexate—systemic scleroderma	2.98e-05	0.000289	CcSEcCtD
